Section 05: Business Model & Economics
Clinical Trial Navigator — Financial Viability & Monetization Strategy
Unit Economics Dashboard
HealthyRevenue Model Overview
The model employs a Hybrid Marketplace Strategy, prioritizing user acquisition through a consumer-facing freemium tool, then monetizing the intent data via B2B lead generation. This lowers the barrier to entry for patients while aligning revenue with the high-value needs of Pharma and CROs.
Primary: B2C Subscription (60%)
Freemium SaaS model with monthly/annual billing.
- Starter: $9.99/mo for unlimited tracking & AI summaries.
- Annual: $99/yr (17% discount) improves cash flow.
- Rationale: Validates product-market fit directly with end-users; provides predictable recurring revenue.
Secondary: B2B Lead Gen (30%)
Cost-per-qualified-lead (CPQL) model for Pharma/CROs.
- Pricing: $50 - $150 per qualified patient hand-off.
- Rationale: Solves the $2B recruitment bottleneck; high willingness to pay for patients meeting specific criteria.
Tertiary: Enterprise (10%)
White-label licensing for Health Systems.
- Pricing: $25k - $50k annual license.
- Rationale: Hospitals need to keep patients in their ecosystem; provides high-touch, high-margin contracts.
Pricing Strategy & Tiers
| Tier | Target | Price | Key Features | Limits |
|---|---|---|---|---|
| Free | Newly diagnosed patients | $0 | Basic search, 3 saved trials, eligibility check | 5 matches/mo |
| Premium | Chronic/Caregiver users | $9.99/mo | AI summaries, alerts, logistics helper, export PDF | Unlimited |
| Enterprise | Health Systems | Custom | White-label, EMR integration, SSO, dedicated support | Volume-based |
The $9.99 price point is a "no-brainer" compared to the cost of alternative treatments or the time spent manually searching. It anchors against high-value medical services while remaining accessible. The primary competitor, ClinicalTrials.gov, is free but offers zero user support; we charge for the translation of complexity into clarity. The $9.99 price is also below the typical $15-$20 threshold for mental friction in app stores.
Customer Acquisition Economics (CAC)
| Channel | Spend | Leads | CAC |
|---|---|---|---|
| Content/SEO | $2,000 | 400 | $5 |
| Paid Social (IG/FB) | $3,000 | 100 | $30 |
| Search Ads (Google) | $2,500 | 50 | $50 |
| Total | $7,500 | 550 | $13.60 |
*CAC reflects cost per sign-up. Paying CAC is higher due to conversion rates.
CAC Improvement Plan
-
Phase 1
High Intent SEO: Create "Condition X Clinical Trial 2024" guides. Target long-tail keywords with high urgency but low CPC.
-
Phase 2
Advocacy Group Partners: Partner with non-profits (e.g., Leukemia & Lymphoma Society). Zero cost CAC, high trust.
-
Phase 3
Referral Engine: "Caregiver Circle" — allow users to invite family members to track their progress, reducing churn and lowering acquisition cost.
Lifetime Value (LTV) Analysis
LTV Calculation (B2C Only)
LTV = ARPU × Gross Margin × (1 / Churn)
LTV = $9.50 × 0.78 × (1 / 0.075)
LTV = $7.41 × 13.3 months
LTV ≈ $98.50
Total Economic LTV (incl. B2B Lead Value): Assuming 1 in 10 users generates a qualified B2B lead valued at $50, the effective LTV increases by $5. Total LTV ≈ $103.50.
Cost Structure & Margins
Fixed Costs (Monthly)
| Personnel (2 Founders) | $10,000 |
| Tech Stack (Hosting/APIs) | $1,500 |
| Legal/Compliance | $1,000 |
| Marketing/Ops | $2,500 |
| Total Fixed | $15,000 |
Variable Costs (Per User/Mo)
| LLM API Usage (GPT-4/Claude) | $1.50 |
| Database/Storage | $0.30 |
| Transaction Fees | $0.30 |
| Support | $0.40 |
| Total Variable | $2.50 |
Break-Even Analysis
Path to Profitability:
| Month | Paying Users | MRR | Burn Rate | Cash Position |
|---|---|---|---|---|
| Month 6 | 500 | $4,750 | -$10,250 | -$88,500 |
| Month 12 | 1,500 | $14,250 | -$750 | -$153,000 |
| Month 14 | 2,150 | $20,425 | +$0 | -$153,000 |
| Month 18 | 3,000 | $28,500 | +$13,500 | -$126,000 |
*Assumes $150k initial seed funding. Break-even occurs Month 14 with ~2,150 paying users.
3-Year Revenue Projections
| Metric | Year 1 | Year 2 | Year 3 |
|---|---|---|---|
| Active Users | 5,000 | 25,000 | 75,000 |
| Paying Users | 750 | 5,000 | 20,000 |
| Conversion Rate | 15% | 20% | 26% |
| B2C Revenue | $85,000 | $570,000 | $2,280,000 |
| B2B Revenue | $50,000 | $300,000 | $1,200,000 |
| Total Revenue | $135,000 | $870,000 | $3,480,000 |
| Gross Margin | 72% | 78% | 82% |
Business Model Risks & Mitigations
Medical Liability Risk
Users may rely on app info as medical advice rather than research assistance.
Mitigation: Robust disclaimers on every screen; "Consult your doctor" CTAs; Terms of Service explicitly limiting liability; structured data inputs that prevent free-text medical advice queries.
Data Accuracy & Hallucinations
LLMs may misinterpret complex eligibility criteria, leading to false hope or wasted time.
Mitigation: RAG (Retrieval-Augmented Generation) architecture grounding responses in official trial text; "Source" links to original criteria; user feedback flagging mechanism for inaccurate summaries.
B2B Sales Cycle Length
Pharma contracts take 6-12 months, creating a cash flow gap.
Mitigation: Focus on "Pilot" programs (3-month, low barrier) to prove ROI; prioritize B2C revenue for early survival; utilize "self-serve" ad options for smaller CROs to bypass sales teams.
Regulatory & Legal
- HIPAA Compliance: Required for handling PHI (Protected Health Information). Must implement BAA (Business Associate Agreements) with all vendors (AWS, OpenAI).
- Data Privacy: GDPR (EU) and CCPA (California) compliance is mandatory for handling health data. "Right to be forgotten" implementation required.
- Entity Structure: Delaware C-Corp recommended to facilitate VC investment and potential acquisition by health-tech giants.
- Insurance: Cyber Liability ($1M coverage) and Errors & Omissions (E&O) are essential.
Funding Strategy
Seed Round: $500,000
To achieve 18-month runway and reach critical mass of 2,000 paying users + 3 B2B pilot partners.
| Product/Engineering | $250,000 (50%) |
| Growth & Marketing | $100,000 (20%) |
| Clinical/Legal Ops | $100,000 (20%) |
| Admin/Reserve | $50,000 (10%) |
Alternative Models Considered
Rejected: Ad-Supported Free Model
Why: Displaying ads for treatments or insurance on a platform for vulnerable patients creates trust issues and conflicts of interest. CPMs for health search are high, but conversion requires aggressive tracking that violates user privacy expectations.
Rejected: Pure B2B SaaS (Recruitment Platform)
Why: Building a patient-facing app is necessary to gather the intent data. A pure dashboard for recruiters offers no differentiation against established players like Antidote or TrialSpark without the proprietary patient network.